76 articles
A. Michael Lincoff
A. Michael Lincoff is an American interventional cardiologist at Cleveland Clinic who led major cardiovascular trials, including SELECT, which showed semaglutide reduced cardiovascular events by 20 percent in 2023.
Adnan Kastrati
Adnan Kastrati, born 1955, is an interventional cardiologist and professor at the Technical University of Munich who designed the ISAR trials and led ISAR-REACT 5.
Albert Schömig
Albert Schömig, born 1946, is a German cardiologist who led the ISAR trials of antiplatelet therapy after coronary stenting and held the Chair of Internal Medicine at the Technical University of Munich from 1992 to 2012.
Antonio Colombo
Antonio Colombo, born in 1950 in Busto Arsizio, Italy, is an interventional cardiologist at Humanitas in Milan known for showing coronary stenting could safely be done without anticoagulation.
Bernard De Bruyne
Bernard De Bruyne is a Belgian interventional cardiologist at the Cardiovascular Center Aalst who developed fractional flow reserve and led the FAME trials showing FFR-guided stenting improves outcomes.
Bernard Prendergast
Bernard Prendergast is a cardiologist specializing in valvular heart disease and structural intervention, Chair of Cardiology at Cleveland Clinic London and a consultant at St Thomas' Hospital.
Bernhard Meier
Bernhard Meier, born 1950 in Bern, is a Swiss interventional cardiologist who led cardiology at the Inselspital from 1992 to 2015 and ran PFO closure trials.
Borja Ibáñez
Borja Ibáñez is a Spanish interventional cardiologist and Scientific Director of the Spanish National Centre for Cardiovascular Research (CNIC) in Madrid, best known for leading the REBOOT trial.
Brahmajee K. Nallamothu
Brahmajee K. Nallamothu, also published as Brahmajee Nallamothu, is an American interventional cardiologist at the University of Michigan known for research on door-to-balloon times in heart attack care.
C. Michael Gibson
C. Michael Gibson is an American interventional cardiologist, Harvard Medical School professor, and CEO of the Baim Institute, known for the TIMI Frame Count and trials like TWILIGHT.
Christian Spaulding
Christian Spaulding is a French interventional cardiologist, professor of cardiology at Université Paris Cité, known for his 1997 study of coronary angiography after out-of-hospital cardiac arrest and drug-eluting stent safety.
Christian W. Hamm
Christian W. Hamm, born 1953 in Hamburg, is a German interventional cardiologist known for 1990s NEJM troponin studies and for leading the Kerckhoff Heart and Thorax Center in Bad Nauheim.
Christodoulos Stefanadis
Christodoulos Stefanadis (Greek: Χριστόδουλος Στεφανάδης) is a Greek cardiologist born in Ikaria who directed cardiology at Hippokration Hospital in Athens from 2002 to 2014 and entered parliament in 2019.
Christoph Nienaber
Christoph Nienaber is a German cardiologist and interventional specialist at Royal Brompton Hospital in London since 2015, known for pioneering endovascular stent-graft treatment of aortic dissection.
Cindy L. Grines
Cindy L. Grines is an American interventional cardiologist who led the PAMI trials showing angioplasty beats clot-dissolving drugs for heart attacks, and is chief scientific officer at Northside Hospital Cardiovascular Institute in Atlanta.
David Erlinge
David Erlinge (D Erlinge) is a Swedish cardiologist, Professor of Cardiology at Lund University, and head of cardiology at Skåne University Hospital, known for leading major coronary trials.
David J. Cohen
David J. Cohen is an American interventional cardiologist and outcomes researcher, Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation in New York.
David P. Faxon
David P. Faxon is an American interventional cardiologist, a Senior Scholar at Brigham and Women's Hospital in Boston and President of the American Heart Association in 2001.
Dean J. Kereiakes
Dean J. Kereiakes, also known as Dean Kereiakes, is an American interventional cardiologist who chairs The Christ Hospital Heart and Vascular Institute in Cincinnati, Ohio.
Dominick J. Angiolillo
Dominick J. Angiolillo is an Italian-born American cardiologist who is Chief of Cardiology at the University of Florida – Jacksonville, known for pioneering personalized antiplatelet therapy in coronary interventions.
Donald E. Cutlip
Donald E. Cutlip is an American interventional cardiologist, Professor of Medicine at Harvard Medical School, and Chief Medical Officer of the Baim Institute for Clinical Research in Boston.
Donald S. Baim
Donald S. Baim was an American interventional cardiologist who founded Beth Israel Hospital's cardiology program, edited Grossman's cardiac catheterization textbook, and became Boston Scientific's chief medical officer.
Edwin L. Alderman
Edwin L. Alderman was an American cardiologist and Stanford professor of cardiovascular medicine who led randomized trials of coronary bypass surgery and angioplasty, including the Coronary Artery Surgery Study.
Éric Van Belle
Éric Van Belle (born 1964) is a French interventional cardiologist who directs interventional cardiology at Lille University Hospital and is known for von Willebrand factor research.
Felix Zijlstra
Felix Zijlstra is a Dutch interventional cardiologist, head of cardiology at Erasmus MC in Rotterdam, known for the Zwolle trials and for chairing the TAPAS thrombus-aspiration trial.
Franz–Josef Neumann
Franz–Josef Neumann is a German interventional cardiologist who directed cardiology at the Heart Centre Bad Krozingen from 2001 to 2022 and chaired the 2018 ESC/EACTS revascularization guidelines.
George Dangas
George D. Dangas is an interventional cardiologist at the Icahn School of Medicine at Mount Sinai in New York, known for leading the GALILEO trial of rivaroxaban after TAVR.
Giulio Stefanini
Giulio Giuseppe Stefanini is an Italian interventional cardiologist and Professor of Cardiology at Humanitas University in Milan, known for his 2013 New England Journal review of drug-eluting stents.
Gregg W. Stone
Gregg W. Stone is an American interventional cardiologist at the Icahn School of Medicine at Mount Sinai, known for leading the COAPT and ISCHEMIA trials.
Hitinder S. Gurm
Hitinder S. Gurm is an interventional cardiologist at the University of Michigan who directs the statewide BMC2 quality collaborative and serves as interim Chief Medical Officer of Michigan Medicine.